Effect of Mineralocorticoid Receptor Antagonism and ACE Inhibition on Angiotensin Profiles in Diabetic Kidney Disease: An Exploratory Study

BACKGROUND: Renin–angiotensin–aldosterone system (RAAS) blockade with angiotensin-converting enzyme inhibitors (ACEi) or angiotensin receptor blockers (ARB) is the cornerstone of antihypertensive treatment in patients with chronic kidney disease (CKD) and diabetes mellitus. Mineralocorticoid recepto...

Descripción completa

Detalles Bibliográficos
Autores principales: Kovarik, Johannes J., Kaltenecker, Christopher C., Domenig, Oliver, Antlanger, Marlies, Poglitsch, Marko, Kopecky, Chantal, Säemann, Marcus D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8384966/
https://www.ncbi.nlm.nih.gov/pubmed/34351585
http://dx.doi.org/10.1007/s13300-021-01118-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8384966/
https://www.ncbi.nlm.nih.gov/pubmed/34351585
http://dx.doi.org/10.1007/s13300-021-01118-7

Ejemplares similares